Ainos, Inc. (NASDAQ:AIMD) Sees Significant Decline in Short Interest

Ainos, Inc. (NASDAQ:AIMD) saw a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 32,693 shares, a decline of 60.9% from the February 26th total of 83,517 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average trading volume of 27,436 shares, the days-to-cover ratio is currently 1.2 days.

Ainos Stock Performance

Shares of Ainos stock opened at $1.44 on Thursday. The stock’s fifty day simple moving average is $1.67 and its 200 day simple moving average is $2.42. The company has a current ratio of 2.96, a quick ratio of 2.67 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $6.93 million, a PE ratio of -0.36 and a beta of 2.39. Ainos has a 12 month low of $1.26 and a 12 month high of $4.50.

Insider Buying and Selling at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the company’s stock in a transaction on Wednesday, January 28th. The stock was sold at an average price of $2.17, for a total transaction of $99,820.00. Following the transaction, the insider owned 989,925 shares of the company’s stock, valued at $2,148,137.25. This represents a 4.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold a total of 47,281 shares of company stock worth $102,152 in the last ninety days. Insiders own 9.79% of the company’s stock.

Institutional Investors Weigh In On Ainos

Hedge funds have recently modified their holdings of the business. Mariner LLC bought a new position in shares of Ainos during the 4th quarter valued at about $37,000. Two Sigma Investments LP acquired a new position in shares of Ainos in the 3rd quarter valued at approximately $80,000. DRW Securities LLC increased its stake in Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after purchasing an additional 48,439 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after purchasing an additional 7,700 shares in the last quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Ainos in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ainos presently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.